Manal Elsayed
Ain Shams University
27 Papers
48 Citations
Manal Elsayed is an academic researcher from Ain Shams University. The author has contributed to research in topics: Heritability & Population. The author has an hindex of 9, co-authored 24 publications.
Chat about Author
Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
510
Towards realistic estimates of HCV incidence in Egypt.
Romulus Breban,Wahid Doss,Gamal Esmat,Manal Elsayed,Margaret Hellard,Margaret Hellard,Margaret Hellard,Patrick Ayscue,Mattew Albert,Mattew Albert,Arnaud Fontanet,Arnaud Fontanet,Mostafa K. Mohamed +12 more
TL;DR: The key assumption of these models of a stationary epidemic is invalid and an alternate approach to estimating incidence based on analysing cohort data is proposed; it is found that the number of annual new infections is <150 000.
65
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Sophia Schroeder,Sophia Schroeder,Alisa Pedrana,Alisa Pedrana,Nick Scott,David Wilson,David Wilson,Christian Kuschel,Lisa Aufegger,Rifat Atun,Ricardo Baptista-Leite,Ricardo Baptista-Leite,Maia Butsashvili,Manal Elsayed,Aneley Getahun,Saeed Hamid,Radi Hammad,Ellen 't Hoen,Sharon J. Hutchinson,Sharon J. Hutchinson,Jeffrey V. Lazarus,Olufunmilayo A. Lesi,Wangsheng Li,Rosmawati Mohamed,Sigurdur Olafsson,Raquel Peck,Annette H. Sohn,Mark W. Sonderup,C W Spearman,Tracy Swan,Mark Thursz,Tim Walker,Margaret Hellard,Jessica Howell,Jessica Howell,Jessica Howell +35 more
TL;DR: Eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints.
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework.
Ste.phanie Popping,Manal Elsayed,Jordan J. Feld,Angelos Hatzakis,Margaret Hellard,Olufunmilayo A. Lesi,Michael Ninburg,John W. Ward,Charles A. Boucher +8 more
TL;DR: An expert panel made of clinicians, virologists, and public health specialists to discuss and address challenges to attempt at facilitating HCV elimination is established.
27
The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
Nick Scott,Nick Scott,David Wilson,David Wilson,Alexander J. Thompson,Alexander J. Thompson,Eleanor Barnes,Manal Elsayed,Adele Schwartz Benzaken,Heidi E. Drummer,Heidi E. Drummer,Heidi E. Drummer,Margaret Hellard +12 more
TL;DR: The case for hepatitis C vaccine development as an urgent public health need is strongly supported to ensure hepatitis C elimination is achievable and at substantially reduced costs for a majority of countries.